Roche Diabetes Care GmbH v.Tandem Diabetes Care, Inc. and Tandem Diabetes Care Europe B.V.
Paris (FR) Central Division - Seat · UPC-000738
The Court of First Instance of the Unified Patent Court (Central Division, Paris seat) issued a cost decision following a revocation action concerning European patent EP 2 196 231 B1. The applicant, Roche Diabetes Care GmbH, sought reimbursement of costs from the respondents, Tandem Diabetes Care, Inc. and Tandem Diabetes Care Europe B.V. The Court dismissed the respondents' request to stay the cost proceedings pending appeal and determined the recoverable costs at EUR 117,741.62, ordering the respondents to pay jointly and severally within three weeks.